AP1100A - Pharaceutical compositions containing eletriptan hemisulphate. - Google Patents

Pharaceutical compositions containing eletriptan hemisulphate. Download PDF

Info

Publication number
AP1100A
AP1100A APAP/P/1998/001290A AP9801290A AP1100A AP 1100 A AP1100 A AP 1100A AP 9801290 A AP9801290 A AP 9801290A AP 1100 A AP1100 A AP 1100A
Authority
AP
ARIPO
Prior art keywords
composition
volume
weight
present
ethanol
Prior art date
Application number
APAP/P/1998/001290A
Other languages
English (en)
Other versions
AP9801290A0 (en
Inventor
Valerie Denise Harding
Anne Billotte
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AP9801290A0 publication Critical patent/AP9801290A0/xx
Application granted granted Critical
Publication of AP1100A publication Critical patent/AP1100A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Packaging Of Annular Or Rod-Shaped Articles, Wearing Apparel, Cassettes, Or The Like (AREA)
  • Medicines Containing Plant Substances (AREA)
APAP/P/1998/001290A 1997-07-03 1998-07-02 Pharaceutical compositions containing eletriptan hemisulphate. AP1100A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9714081.8A GB9714081D0 (en) 1997-07-03 1997-07-03 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
AP9801290A0 AP9801290A0 (en) 1998-09-30
AP1100A true AP1100A (en) 2002-09-02

Family

ID=10815339

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1998/001290A AP1100A (en) 1997-07-03 1998-07-02 Pharaceutical compositions containing eletriptan hemisulphate.

Country Status (13)

Country Link
KR (1) KR100384346B1 (ko)
AP (1) AP1100A (ko)
AR (1) AR013165A1 (ko)
CO (1) CO4950555A1 (ko)
GB (2) GB9714081D0 (ko)
GT (1) GT199800105A (ko)
HN (1) HN1998000101A (ko)
MY (1) MY119643A (ko)
PA (1) PA8454501A1 (ko)
PE (1) PE84499A1 (ko)
TN (1) TNSN98126A1 (ko)
UA (1) UA49955C2 (ko)
ZA (1) ZA985812B (ko)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006842A1 (en) * 1994-08-27 1996-03-07 Pfizer Limited Salts of an anti-migraine indole derivative

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006842A1 (en) * 1994-08-27 1996-03-07 Pfizer Limited Salts of an anti-migraine indole derivative

Also Published As

Publication number Publication date
GB9714081D0 (en) 1997-09-10
PE84499A1 (es) 1999-09-11
ZA985812B (en) 2000-01-10
GB9718270D0 (en) 1997-11-05
CO4950555A1 (es) 2000-09-01
MY119643A (en) 2005-06-30
KR20010014366A (ko) 2001-02-26
UA49955C2 (uk) 2002-10-15
AR013165A1 (es) 2000-12-13
PA8454501A1 (es) 2000-05-24
KR100384346B1 (ko) 2003-05-16
HN1998000101A (es) 1999-01-08
GT199800105A (es) 2000-01-04
AP9801290A0 (en) 1998-09-30
TNSN98126A1 (fr) 2005-03-15

Similar Documents

Publication Publication Date Title
US6166025A (en) Pharmaceutical compositions containing eletriptran hemisulphate and caffeine
RU2762725C2 (ru) Композиции, содержащие триптановые соединения
EP1196156B1 (en) Transnasal anticonvulsive compositions
HU199678B (en) Process for producing aerosols containing nitroglicerol
US5169849A (en) Nasal pharmaceutical compositions
JPH07309761A (ja) デュオカルマイシン誘導体の安定化法
CA2100569A1 (en) Compositions
US6007834A (en) Nasal melatonin composition
US4885305A (en) Nasal compositions
AP1100A (en) Pharaceutical compositions containing eletriptan hemisulphate.
US5874450A (en) Intranasal formulations for promoting sleep and method of using the same
AU2001282521B2 (en) OCT preparations
GB2114001A (en) Nasal pharmaceutical compositions
MXPA99011299A (en) Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
CZ466099A3 (cs) Farmaceutické kompozice obsahující elektriptanhemisulfat a kofein
CA1197783A (en) Nasal pharmaceutical compositions
US6228836B1 (en) Permucous preparation
JPH02286618A (ja) フイゾスチグミンおよびアレコリンの鼻内投与用製剤